Italy's Newron Pharmaceuticals has disclosed that the FDA kept U.S. enrollment in a Phase 3 trial of its schizophrenia drug evenamide on hold, citing five deaths across all the drug's clinical studies ...
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results